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Abstract: Veronica persica (Persian speedwell) is a flowering plant local to Eurasia. In this study, several analyses were done to discover the antimicrobial and 
scolicidal activities and acetyl cholinesterase (AChE), tyrosinase (TYR), lipoxygenase (LOX), and xanthine oxidase (XO) inhibitory activities of V. persica extract. 
The results presented that B. subtilis was the most susceptible to the extract (MIC = 40.3 μg/mL), while P. aeruginosa was the most resistant strain (MIC = 250.9 
μg/mL) among all bacteria evaluated. The extracts demonstrated significant activity versus E. granulosus (P < 0.5) with dose-dependent inhibitions of the protos-
colices. The analyzed plant extract exhibited a high AChE and TYR inhibitory activity 55.3% and 52.7% (at the highest utilized dose – 3 mg/mL), respectively. The 
extract also showed high anti-inflammatory activities in analyses tested. Our research proposed that extract of this plant could be promising to the human health, 
markedly in the infectious, neurodegenerative and inflammatory disorders.
Key words: Plantaginaceae; Antimicrobial activity; Neuroprotective ativity; Anti-inflammatory activity; Antioxidant activity.
Introduction
For thousands of years, medicinal plants repre-
sented a significant source of remedies, as well as the 
basis of traditional or indigenous healing systems still 
highly utilized by the population in the world (1-4). In 
recent years, medicinal plant therapy has been shown 
to be useful for treatment of various human and animal 
diseases (2-15).The unnecessary and frequent use of the 
same drugs used in modern medication has resulted in 
the evolution of an tibiotic-resistant microbes (1, 2, 8-10, 
16). In traditional medical science, a large number of 
therapeutic plants have presented antimicrobial effects 
and many of these have been used for the treatment of 
different infec tious diseases (2, 8, 17-26). 
Alzheimer’s disease (AD) is an advancing neurode-
generative disease influencing 25 million people world-
wide, and AChE is the most likely mark for the treat-
ment of AD among cholinergic hypothesis (27). Several 
plants have been established as containing acetylcholi-
nesterase inhibitory (AChEI) activity (28-31). 
Tyrosinase (TYR), a multifunctional Cu-containing 
enzyme, catalyzes melanin synthesis in melanocytes 
(32). It has also been related to Parkinson’s disease (33). 
Some TYR inhibitors from natural resources have been 
documented (34, 35).
Lipoxygenases (LOXs) are enzymes associated with 
inflammatory and allergic reactions because of the pro-
duction of eicosanoid leukotrienes and lipoxins, and 
principal biological mediators of inflammatory pro-
cesses (36). Alam et al. (37) indicated LOX herb inhi-
bitor that can be a source of valuable alternative thera-
peutic agent.
Xanthine oxidase (XO) catalyzes the oxidation of 
hypoxanthine into xanthine and uric acid during the 
metabolic processes of purines (38) accompanied by the 
production of reactive oxygen species (ROS) (39). XO 
is involved in the medical state known as gout, which 
is marked by hyperuricemia that causes uric acid de-
position in the joints resulting in painful inflammation. 
Some research groups have done screening XO inhi-
bitors from local medicinal plants that can perhaps be 
developed into clinical products (40-43).
The genus Veronica L. is the largest genus of the 
Plantaginaceae family, with about 500 species that 
showed a wide ecological variability. Recently, we re-
ported an antioxidant capacity of V. persica phenolic-
rich extracts (1); and according to the literature, there 
are no other data of its biological activity. In this study, 
antimicrobial, scolicidal activities and AChE, TYR, 
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LOX, XO inhibitory activities of the extract prepared 
from V. persica were determined. The goal of this study 
was to discover a new source of effective medicine for 
treating infectious, neurodegenerative and inflamma-
tory diseases.
Materials and Methods
Plant material and extraction conditions
The aerial parts (stems, leaves, and flowers) of Vero-
nica persica Poir. were collected at flowering stage, in 
April 2016, from wild plants in the mountains of Mey-
mand, Firuzabad County, Fars Province, Iran (Coordi-
nates: 28°52′04″N 52°45′12″E). A botanist taxonomi-
cally identified the plant. All plant material collected 
dried in the shade, then pulverized into a fine powder 
using a grinder sieved through a No. 22 mesh sieve and 
stored in an air-tight container until required for the ex-
periment. A volume of 200 mL of 70% methanol was 
added to 20 g of powder and kept on a mechanical sha-
ker for 72 h. The content was filtered and concentrated 
under reduced pressure under controlled temperature to 
yield a dark gummy residue. The concentrated extract 
was stored dry in amber-colored flasks at 4 °C for upco-
ming experiments.
Antimicrobial activity assay
The antimicrobial activity of the extracts was as-
sayed against two Gram-positive bacteria (Staphylo-
coccus aureus ATCC 6538 and Bacillus subtilis ATCC 
6633), two Gram-negative bacteria (Klebsiella pneumo-
niae ATCC 10031 and Pseudomonas aeruginosa ATCC 
9027) and two fungi (Candida albicans ATCC 10231 
and Aspergillus niger ATCC 9142). All microorganisms 
were obtained from the Persian Type Culture Collec-
tion, Tehran, Iran.
The fungi and bacteria were cultured for 14-24 h at 
37 °C and the densities were adjusted to 0.5 McFarland 
standards at 530 nm. The antibacterial experiments 
were performed by the disc diffusion method (44). 
Of the 100 μL microbial suspensions were spread on 
nutrient agar (Merck, Germany) plates (100 mm × 15 
mm). Discs (6 mm diameter) were impregnated with 
100 μL of different concentrations of extract (50, 100, 
150, and 300 μg/mL) and placed on the inoculated agar. 
All the inoculated plates were incubated for 24 h at 37 
°C. In this assay positive control discs used included ke-
toconazole, gentamicin and ampicillin (10 mg/disc) for 
fungi, Gram-negative and Gram-positive bacteria, res-
pectively. Furthermore, we used 5% dimethyl sulfoxide 
(DMSO) as the negative control. Antimicrobial activi-
ty was appraised by measuring the zone of inhibition. 
Minimum inhibitory concentration (MIC) was determi-
ned using serial dilutions of the extracts (0-500 μg/mL) 
using microdilution experiment approved by Clinical 
and Laboratory Standards Institute (45). The bacteria 
and fungi were suspended in Luria-Bertani media and 
the densities were regulated to 0.5 McFarland standards 
at A530 nm (108 CFU/mL). The extract (100 μL) and 
the bacteria and fungi suspensions (100 μL) were ad-
ded to microtiter plates and incubated at 37 °C for 24 h. 
The medium with bacteria and fungi but without extract 
was used as growth control and medium without bac-
teria and fungi was as sterility control. Growth in each 
well was compared with the growth in the control well. 
The MICs values were visually detected in comparison 
with the growth in the control well and delineated as 
the lowest concentration of the components with >95% 
growth inhibition.
Scolicidal activity
The scolicidal activity, Echinococcus granulosus 
protoscolices were gained from the infected livers of 
calves killed in an abattoir. Animals were treated hu-
manely according to the Helsinki Convention. Hydatid 
fluid was collected together with protoscolices using the 
Smyth and Barrett (46) assay.
Briefly, the hydatid fluid was transferred to a glass 
cylinder. Protoscolices, which settled at the bottom 
of the cylinder after 40 min, were washed three times 
with normal saline and their viability was verified by 
motility under a light microscope (Nikon Eclipse E200, 
Japan). Protoscolices were transferred into a dark re-
ceptacle comprising normal saline and stored at 4 °C. 
Three concentrations of plant extract (5, 10, and 15 mg/
mL) were assayed for 10, 20, 30 and 60 min. To prepare 
these concentrations 50, 150 and 100 µL of extracts, 
added to test tubes, were dissolved in 9.7 mL of normal 
saline supplemented with 0.5 mL of Tween-80 (Merck, 
Darmstadt, Germany) under continuous stirring. For 
each assay, one drop of protoscolex-rich solution was 
added to 3 mL of the extract solution, mixed slowly, and 
incubated at 37 °C. After each incubation period (10, 
20, 30 and 60 min), the upper phase was carefully remo-
ved so as not to disturb the protoscolices, then 1 mL of 
0.1% eosin stain was added to the remaining colonized 
protoscolices and mixed slowly. After incubating for 20 
min at 25 °C, the supernatant was discarded. The remai-
ning pellet of protoscolices (no centrifugation carried 
out) was then smeared on a manually scaled glass slide, 
covered with a cover glass, and evaluated under a light 
microscope. The percentage of dead protoscolices was 
determined after counting a minimum of 600 protos-
colices. In the control, protoscolices were treated only 
with normal saline + Tween-80. 
Acetylcholinesterase inhibition assay
In this study, the acetylcholinesterase inhibition acti-
vity was determined by the method illustrated by Ingka-
ninan et al. (47). In brief, 3 mL of 50 mM Tris–HCl buf-
fer (pH 8.0), 100 µL of plant extract at various concen-
trations (0.5, 1.5, 3 mg/mL) and 20 µL AChE (6 U/mL) 
solution were mixed and incubated for 15 min at 30 ºC; 
a 50 µL volume of 3 mM 5,50-dithiobis-(2-nitrobenzoic 
acid) (DTNB) was added to this mixture. The reaction 
was then started with by the addition of 50 µL of 15 
mM acetylthiocholine iodide (AChl). The hydrolysis 
of this substrate was observed at 405 nm in a Hitachi 
U-2001 spectrophotometer (Tokyo, Japan). The forma-
tion of yellow 5-thio-2-nitrobenzoate anion was noticed 
as the result of the reaction of DTNB with thiocholine, 
released by the enzymatic hydrolysis of acetylthiocho-
line iodide. The enzymatic activity was determined as 
a percentage of the velocities compared to that of the 
experiment by buffer instead of inhibitor (plant extract), 
as follows: 
EA= E-S/E × 100
In this formula, E is the activity of the enzyme wit-
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and Timothy (50) with slight modifications. Briefly, the 
assay mixture consisted of 150 μL of phosphate buffer 
(0.066 M; pH 7.5), 50 μL of extract solution (1 mg/
mL in phosphate buffer), and 50 μL of enzyme solution 
(0.28 U/mL). After pre-incubation at room temperature 
(25 °C) for 3 minutes, the reaction was initiated by addi-
tion of 250 μL of substrate solution (Xanthine, 0.15 M 
in the same buffer). A blank without enzyme solution 
was also prepared. The reaction was monitored for 3 
min at 295 nm and velocity (Vo) was recorded. Phos-
phate buffer was used as negative control (activity of the 
enzyme without extract solution). Allopurinol was used 
as positive control. The percentage of xanthine oxidase 
inhibition was calculated using the following formula:
% Inhibition = [(Vo control- Vo sample) × 100]/Vo 
control
where Vo control is the activity of enzyme without ma-
cerate/fraction and Vo sample is the enzyme activity in 
presence of macerate/fraction or allopurinol.
Statistical analysis
All the experiments were carried out in triplicate. 
Data were subjected to one-way analysis of variance 
(ANOVA) followed by Tukey’s HSD (honestly signifi-
cant difference) post-hoc test at P < 0.05 using SPSS v. 
11.5. Data are expressed as a mean ± standard deviation.
Results
The antibacterial activity of the extract is summa-
hout the experiment sample and S is the activity of the 
enzyme with the experiment sample.
Tyrosinase inhibition assay
To assay, the tyrosinase inhibition used the 
method described by Liang et al. (48). The tyrosinase 
(EC1.14.1.8.1, Sigma) activity was spectrophotometri-
cally measured on 3-(3,4-dihydroxyphenyl)-L-alanine 
(L-DOPA) (Sigma-Aldrich) as substrate. Tyrosinase 
aqueous solution (100 µL, 0.5 mg/mL), plant extract 
(0.5, 1.5, 3 mg/L) and 1850 µL of 0.2 M phosphate buf-
fer (pH 7.0) were mixed and incubated for 15 min at 30 
ºC. Following, 10 mM L-DOPA solution (50 µL) was 
added and the absorbance at 475 nm was measured for 
3 min against a blank in a Hitachi U-2001 spectropho-
tometer (Tokyo, Japan). The same reaction mixture ha-
ving the plant extract replaced by the equivalent amount 
of phosphate buffer, as blank. The % inhibition of tyro-
sinase activity was measured based on the formula:
% Tyrosinase inhibition= A control – A sample / A control × 100
where A control is the change of absorbance at 475 nm wit-
hout a test sample, and A sample is the change of absor-
bance at 475 nm with a test sample.
Lipoxygenase inhibition assay
The lipoxygenase (LOX) inhibiting activity was 
measured using spectrophotometrically as illustrated 
by Lycklander and Malterud (49) with slight modifica-
tions. Briefly, 100 μL of the enzyme solution (at the final 
concentration of 200 U/mL) was prepared in boric acid 
buffer (0.2 M; pH= 9) and mixed with 25 μL of extract 
solution (1 mg/mL in boric acid buffer) and then incu-
bated at room temperature for 3 min. Reaction was ini-
tiated by the addition of substrate solution (linoleic acid, 
250 μM), and the velocity was recorded for 2 min at 
234 nm against a blank in a Hitachi U-2001 spectropho-
tometer (Tokyo, Japan). Negative control was prepared 
with contained 1% methanol solution without fraction 
solution. Quercetin was used as positive control. The 
percentage of lipoxygenase inhibition was calculated 
according to the following equation:
% Inhibition = [(Vo control- Vo sample) × 100]/Vo control
Where Vo control is the activity of enzyme in absence of 
extract solution, and Vo sample is the activity of the en-
zyme in the presence of extract, quercetin or ibuprofen.
Xanthine oxidase inhibition assay
The xanthine oxidase (XO) inhibition activity was 
measured on a spectrophotometer as illustrated by Owen 
Extract (μg/mL) Staphylococcus aureus Bacillus subtilis Klebsiella pneumoniae Pseudomonas aeruginosa
50 8.5 ± 0.2 e 9.6 ± 0.3 d 7.3 ± 0.1 e 5.5 ± 0.2 e
100 11.5 ± 0.1 d 11.2 ± 0.1 c 8.5 ± 0.4 d 7.7 ± 0.1 d
150 12.3 ± 0.1 c 13.8 ± 0.3 b 9.8 ± 0.1 c 8.3 ± 0.1 c
300 14.4 ± 0.3 b 17.9 ± 0.5 a 13.6 ± 0.3 b 9.5 ± 0.2 b
Ampicillin 15.5 ± 0.3 a 17.8 ± 0.5 a - -
Gentamicin - - 14.5 ± 0.2 a 11.9 ± 0.4 a
DMSO (negative control) 1± 0.0 f 1± 0.0 e 1±0.0 f 1 ± 0.0 f
Data are expressed as means ± SD of inhibition zone diameter (mm) for different concentrations of the plant extract and controls (μg/mL). The 
values with different letters within a column are significantly different (P < 0.05; HSD). DMSO: dimethyl sulfoxide; MIC: minimum inhibitory 
concentration.
Table1. Antibacterial activity of V. persica extract against Gram-positive and Gram-negative bacteria.
Figure 1. MIC values of V. persica extract against four tested bac-
teria. Values are mean of ± SD of three replicates. Means with dif-
ferent letters are significantly different (P < 0.05; HSD).
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rized in Table 1. The results showed that the extract of 
V. persica demonstrated a dose-dependent antibacterial 
effect on the growth of all tested bacteria. The V. persica 
extract showed the maximum zones of inhibition at a 
concentration of 300 μg/mL of extract on the growth of 
all bacte ria. Inhibition zones at a concentration of 300 
μg/mL of the extract were 14.4 ± 0.3, 17.9 ± 0.5, 13.6 
± 0.3, and 9.5 ± 0.2 mm for S. aureus, B. subtilis, K. 
pneumoniae, P. aeruginosa, respectively. Among bacte-
ria, B. subtilis (MIC = 40.3 μg/mL) revealed a high sen-
sitivity to extract of V. persica. The results of antifun-
gal assays are shown in Table 2. The V. persica extract 
inhibited the growth of C. albicans and A. niger in all 
the assayed concentrations (P < 0.05). The maximum 
inhibition zone was detected in concentration 300 μg/
mL of extract. Indeed, the V. persica extract exhibited 
a strong activity against C. albicans  and A. niger fungi 
with an inhibition zone of 9.9 ± 0.1 and 10.9 ± 0.5 mm 
at 300 μg/mL plant extract, respectively. MICs for C. 
albicans and A. niger were 95.5 ± 0.1 and 66.7 ± 0.2 μg/
mL of V. persica extract, respectively. Mortality rates 
of E. granulosus protoscolices after treatment with va-
rious concentrations of V. persica extract is presented 
in Table 3. As exposure time and extracts concentration 
increased, % mortality was also increased. Therefore, 
exposure to the extracts for 60 min, at 5, 10 and 15 mg/
mL led to 58.38%, 72.6%, 91.45% inhibition, respecti-
vely. The mortality in the control was 3.84%, after 60 
min.
The anti-neurodegenerative activity of V. persica 
Extract (μg/mL) Candida albicans Aspergillus niger
50 3.9 ± 0.5 e 5.7 ± 0.5 d
100 4.7 ± 0.8 d 6.6 ± 0.3 c
150 7.9 ± 0.3 c 7.9 ± 0.2 b
300 9.9 ± 0.1 b 10.9 ± 0.5 a
Ketoconazole (μg/mL) 10.5 ± 0.1 a 10.5 ± 0.1 a
DMSO (negative control) 1.3 ± 0.1 f 1.1 ± 0.0 e
MIC 95.5 ± 0.1 66.7 ± 0.2
Data are expressed as means ± SD of inhibition zone diameter (mm) for different concentrations of the plant extract and controls (μg/
mL). The values with different letters within a column are significantly different (P < 0.05; HSD). DMSO: dimethyl sulfoxide; MIC: 
minimum inhibitory concentration. 
Table 2. Antifungal activity of V. persica extracts.
Plant extract
Concentrations (mg/mL) Exposure time (min) Protoscolices Dead protoscolices Mortality (%)
5
10 1829.00 ± 54.21 395.44 ± 18.22 21.59
20 1453.94 ± 70.22 432.25 ± 51.11 29.73
30 1222.53 ± 42. 45 588.33 ± 25.14 48.11
60 1192.74 ± 32.17 696.55 ± 25.51 58.38
Control 1455.00 56.00 3.84
10
10 945.92 ± 22.62 611.45 ± 77.22 64.65
20 799.91 ± 32.81 527.22 ± 17.15 65.95
30 993.74 ± 65.44 669.22 ± 25.33 67.37
60 732.23 ± 33.17 532.00 ± 25.11 72.67
Control 1455.00 56.00 3.84
15
10 934.91 ± 81.12 684.54 ± 17.82 73.23
20 788.45 ± 13.17 675.39 ± 32.11 85.65
30 888.29 ± 39.15 794.92 ± 45.82 89.41
60 995.00 ± 32.00 910.32 ± 42.82 91.45
Control 1455.00 56.00 3.84
Values are mean ± SD of three replicates. In the control, protoscolices were treated only with normal saline + Tween-80.
Table 3. Scolicidal activity of V. persica extract against E. granulosus.
Sample AChE inhibition %
0.5 mg/mL 1.5 mg/mL 3 mg/mL
Veronica persica 35.5 ± 0.48 e 46.45 ± 0.32 d 55.32 ± 0.29 c
Galanthamine 99.86± 0.58 a - -
Rutin 55.35 ± 0.19 b 85.85 ± 0.54 a 90.42 ± 0.39 a
Caffeic acid 52.52 ± 0.32 c 75.99 ± 0.69 c 85.36 ± 0.19 b
Rosmarinic acid 50.45 ± 0.11 d 77.69 ± 0.51 b 85.55 ± 0.23 b
Data represent the mean ± SD of three independent replicates. The values with different letters within a column are significantly 
different (P < 0.05; HSD).
Table 4. Acetylcholinesterase inhibitory activity of V. persica extract.
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extract was examined at concentrations of 0.5, 1.5, and 
3 mg/mL using AChE and TYR assays (Tables 4 and 
5). Inhibition of both enzymes by the extract varied 
between 35.5 to 55.32% for AChE, and from 25.45 to 
52.7% for TYR. A statistically marked difference was 
observed among the different concentrations of the 
extract. The extract exhibited statistically weaker acti-
vity than the standards galanthamine, rutin, caffeic acid 
and rosmarinic acid for AChE assay, and ellagic acid, 
quercetin, rutin and kojic acid for TYR experiment. The 
extract of V. persica presented stronger inhibitory effect 
at the highest concentration (3 mg/mL) in both assays.
V. persica extract demonstrated high anti-inflamma-
tory properties, both in the LOX and XO experiments. 
In the XO experiment, the results showed a high inhibi-
tion of enzyme activity. Finally, when assayed using the 
LOX assay, the extract presented moderate inhibition 
(Table 6).
Discussion
It is well known that active phytochemicals are 
produced for protection of plants against microbial pa-
thogens and those plants can be hopeful sources of new 
compounds with biological activities such as antioxi-
dants and antimicrobials (7, 51, 52). This study demons-
trate that the extract of V. persica possesses extensive 
antibiotic activity against Gram-positive and Gram-ne-
gative bacteria, fungi and E. granulosus. The genus Ve-
ronica  exhibited strong antibacterial activity probably 
due to the high content of flavonoids, phenol carboxylic 
acids and tannin (53). Dunki et al. (54) showed that V. 
spicata is beneficial as phytotherapeutical, antioxidative 
and antimicrobial agent. Also, Mocan et al. (2015) indi-
cated that the use of three Veronica species V. officinalis 
L., V. teucrium L. and V. orchidea Crantz as antimicro-
bial agents (55). Probably, the antimicrobial potential of 
V. persica we observed can be ascribed to the presence 
of polyphenolic compounds.
AD influences memory and other features of human 
mind and is characterized by the loss of activities refer-
ring to the acetylcholine in the cerebral cortex. Notewor-
thy, most of the AChE inhibitors such as galanthamine 
were originally isolated from plants (56). Furthermore, 
it has been demonstrated that TYR might be related to 
the damaged neurons typical for another progressive 
neurological disorder, Parkinson’s disease (57). A num-
ber of polyphenols isolated from plants were established 
as AChE and TYR inhibitors, such as quercetin, kaemp-
ferol and caffeic acid (58). Our study documented the 
activity of V. persica extract against enzymes involved 
in neurodegenerative disorders. Although inhibitory ac-
tivities of the extract were lower than the standard ones 
for those enzymes, the results of our study propose that 
V. persica could be of interest for the development of 
food supplements that could prevent neurodegenerative 
diseases. In a previous study, a moderate neuroprotec-
tive activity of V. jacquinii and V. teucrium extracts was 
reported on human neuroblastoma SH-SY5Y cell line 
(59). In addition, Živković el al. (2017) showed that 
V. teucrium and V. jacquinii methanol extracts inhibit 
AChE and TYR enzymes (60). 
Although Veronica species have been widely utilized 
in the oriental medicine for inflammatory disorders, the 
pharmacological effects of these species have not been 
fully examined. In the present study, V. persica was 
assessed for its inhibitory effect on LOX and XO. XO 
is an enzyme that generates ROS (reactive oxygen spe-
cies) from the chemical reaction it catalyzes. ROS react 
with cellular lipids, resulting in the formation of lipid 
peroxides, which are metabolized to malondialdehyde, 
a major product of lipid peroxidation (61). In our pa-
per, the high inhibition of XO by V. persica extract may 
contribute to its antioxidant effect. V. persica extract 
also demonstrated a moderate inhibition of LOX en-
zyme. LOX are involved in the metabolism of leuko-
trienes (62). The moderate LOX inhibition by V. persica 
extract could partially contribute to the anti-inflamma-
tory activity of the plant extract. The anti-inflammatory 
effects of V. offcinalis  extract on human lung epithelial 
cell line A549 were previously (63). Similarly, the ex-
tracts of three Veronica species, V. jacquinii Baumg., V. 
teucrium L. and V. urticifolia Jacq exhibited LOX inhi-
bitory activity (64). In conclusion, our results indicate 
that V. persica extract could be a promising food sup-
plement for human health, particularly in the prevev-
Sample Tyrosinase inhibition %
0.5 mg/mL 1.5  mg/mL 3 mg/mL
Veronica persica 25.45 ± 0.31 e 35. 33 ± 0.12 e 52.7 ± 0.5 e
Ellagic acid 46.95 ± 0.47 b 66.5 ± 0.26 b 89.42 ± 0.29 b
Quercetin 35.65 ± 0.21 d 55.49 ± 0.11 c 79.84 ± 0.51 d
Rutin 39.59 ± 0.41 c 45.59 ± 0.33 d 80.45 ± 0.33 c
Kojic acid 75.55 ± 0.33 a 85.45 ± 0.39 a 94.44 ± 0.37 a
Data represent the mean ± SD of three independent replicates. The values with different letters within a column are significantly 
different (P < 0.05; HSD).
Table 5. Tyrosinase inhibitory activity of V. persica extract.
Sample Lipoxygenase inhibition (%) Xanthine oxidase inhibition (%)
Veronica persica 55.35 ± 0.45 b 84.99 ± 0.22 b
Quercetin 55.69 ± 0.22 b 85.44 ± 0.32 b
Allopurinol ND 92.54 ± 0.43 a
Ibuprofen 80.38 ± 0.25 a ND
Data represent the mean ± SD of three independent replicates. The values with different letters within a column are significantly different 
(P < 0.05; HSD).
Table. 6. Lipoxygenase and xanthine oxidase inhibitory activities of V. persica extract.
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tion of infectious, neurodegenerative and inflammatory 
disorders.
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